Business
Kansas Senate Panel Tables Medical Cannabis Legalization Bill
A Kansas legislative committee voted on Thursday to table a medical marijuana legalization bill, likely killing the bill for the remainder of the 2023 legislative session.
A Kansas state Senate committee on Thursday voted to table a bill to legalize medical marijuana, likely killing the measure for the remainder of the year. The Senate Federal and State Affairs Committee voted to table the measure, Senate Bill 135, after hearing from advocates on both sides of the issue at a pair of hearings last week. Republican state Representative Mike Thompson, the chair of the panel, said later that he has no plans to bring the bill up for consideration again during the current legislative session, according to a report in local media.
After the committee voted to table the bill, Kansas Governor Laura Kelly expressed her frustration at the development. The Democratic governor, who has previously called on state lawmakers to pass a medical marijuana legalization bill, also urged residents who support cannabis policy reform to contact state lawmakers and call on them to revive the proposal.
“I am disappointed that some legislators are saying they don’t want to move forward with legalizing medical marijuana this year – effectively turning their backs on our veterans and those with chronic pain and seizure disorders,” Kelly wrote on Twitter on Thursday. “If they get their way, for yet another year thousands of Kansans will be forced to choose between breaking the law and living without pain. I encourage Kansans to call their state legislators and tell them to legalize medical marijuana this session.”
If the measure is eventually passed, Senate Bill 135 would legalize the use of cannabis for patients with one or more of 21 serious medical conditions including cancer, epilepsy, spinal cord injuries and chronic pain. Patients would be required to have a doctor’s recommendation to use medical marijuana and pay $50 for a state identification card to participate in the program. Patients would also pay a 10% excise tax on medical cannabis purchases.
The bill would also regulate the cultivation, processing, distribution and sale of medical marijuana. Four different state agencies—the Department of Health and Environment, the Board of Healing Arts, the Department of Revenue’s Alcohol and Beverage Control (which would be renamed to Alcohol and Cannabis Control) and the Board of Pharmacy—would be tasked with oversight of the medical marijuana program. The legislation is slated to go into effect starting in July 2024, according to the text of the measure.
Kansas Activists Call On Lawmakers To Pass Legislation
Prior to Thursday’s vote to table the bill, several witnesses testified before the committee about the legislation at a pair of hearings held last week. Mandy Sohosky, who identified herself as a private citizen, said that cannabis is the best option to treat the chronic migraines that she endures. A host of traditional and alternative therapies including medication, therapy and acupuncture failed to help her, prompting her doctors to prescribe opioids and powerful muscle relaxers. But after trying cannabis in a legal state, she said the pain was gone in 10 minutes.
“There is a solution for my migraines,” Sohosky told lawmakers at a hearing on Wednesday. “It’s not a perfect solution, but it would help me be a more present parent for my kids. I could attend karate practice, go to choir concerts. I could be there for family movie night. There is a solution for my pain. Please allow me to use it while my kids are still young, and my parents are still alive. I have so many memories left to make. Please allow me to make them.”
Supporters of the legislation also noted that the bill would reduce the suffering of thousands of Kansans with serious medical conditions. Appearing before the committee, Alejandro Rangel-Lopez noted that 17 residents of Ford County were arrested for marijuana possession between November and February.
“These are folks my age. I recognize a lot of those names from elementary school, from high school. I graduated with a lot of them,” Rangel-Lopez said. “And it’s heartbreaking because you know what’s going to happen. They get sucked into the criminal justice system, and they end up in parole for years, if not decades. And it ruins their lives. And for what? For what? I don’t think we have anything to show for the criminalization of marijuana. So I’m tired of seeing folks suffer needlessly due to inaction from our lawmakers.”
Senators on the legislative panel also heard from groups on the other side of the issue at a second hearing on Thursday. Representatives of state law enforcement organizations including the Kansas Sheriffs’ Association, the Kansas Association of the Chiefs of Police and the Kansas Peace Officers Association attended the hearing to express opposition to the medical marijuana legalization bill.
Activist Lee Bretz, whose father was issued a ticket by police while in a hospital for terminal cancer, said the committee’s decision is only delaying the inevitable.
“It’s gonna happen, you know, in a matter of time,” Bretz said. “I just don’t know why they keep delaying it.”
Source: https://hightimes.com/news/kansas-senate-panel-tables-medical-cannabis-legalization-bill/
Business
Alleged Crores Pharma Scam Mastermind Arrested from Surat
After evading law enforcement for nearly 13 years, an accused linked to a large-scale pharmaceutical fraud case has been arrested by Delhi Police from Surat, Gujarat. The suspect is alleged to have orchestrated a series of financial scams involving fake identities, forged documents, and dishonoured cheques used to procure high-value pharmaceutical raw materials.
Authorities say the accused, identified as Himmat Singh Lodha, is believed to have defrauded multiple pharmaceutical companies in Delhi of goods worth approximately ₹98 lakh before disappearing and remaining underground for years.
Fake Business Deals and Dishonoured Cheques Used in Fraud
Investigators claim the accused posed as a legitimate pharmaceutical trader and placed bulk orders for expensive drug ingredients, offering post-dated cheques as payment security.
In one documented case from 2013, he allegedly obtained around 550 kilograms of Gliclazide, a diabetes-related pharmaceutical ingredient, valued at over ₹26 lakh. When suppliers attempted to encash the cheques, they were reportedly returned with the remark “account closed.”
Following the transaction, the accused allegedly vacated his office and rented residence and disappeared without settling payments. He was later declared a proclaimed offender in 2016 after repeatedly failing to appear before court proceedings. Authorities had also issued a reward for information leading to his arrest.
Multiple Identities and Repeated Fraud Pattern
Police investigations further link the accused to another cheating case dating back to 2012, where he allegedly used a fake identity, “Kailash Jain,” to obtain a large consignment of Ambroxol HCL, a pharmaceutical compound used in cough medications. The value of that consignment was estimated at around ₹72 lakh.
Officials believe the accused followed a consistent modus operandi—posing as a credible businessman, securing high-value goods on deferred payment terms, and then disappearing after delivery while shutting down business operations.
Investigators suspect that forged business records, fake company credentials, and fabricated financial histories were used to build trust with suppliers and gain access to expensive raw materials.
Multi-State Surveillance Leads to Arrest in Surat
A special Crime Branch team tracked the accused through coordinated surveillance efforts across multiple cities, including Mumbai, Ahmedabad, and Surat. After nearly a month of technical monitoring and intelligence gathering, officials located and arrested him from a residential area in Surat.
Authorities also revealed that the accused had been involved in property-related activities while staying under the radar to avoid detection.
Growing Threat of Corporate Identity Fraud
The case highlights a rising trend of organised financial fraud targeting industries that rely heavily on trust-based transactions and deferred payments. Experts note that criminals increasingly exploit gaps in corporate verification systems by using fake GST registrations, temporary offices, and forged documentation to appear legitimate.
Cybercrime and financial fraud specialists warn that such schemes are becoming more complex with the widespread availability of digital business tools, making it easier to create convincing but fraudulent corporate identities.
Experts Urge Stronger Due Diligence in High-Value Transactions
Experts, including former IPS officer and cybercrime specialist Prof. Triveni Singh, emphasize the need for stricter verification procedures in commercial dealings. He noted that relying solely on paperwork or digital business profiles can expose companies to significant financial risk.
Authorities and industry experts recommend physical verification of business operations, bank account validation, and detailed background checks before engaging in high-value or deferred-payment transactions—particularly in sectors like pharmaceuticals, where single consignments can involve transactions worth crores.
Business
EU Pressure Builds on Google as Regulators Face Calls for Massive Fine Over Search Practices
A growing coalition of European industry groups is intensifying pressure on regulators to take decisive action against Google over allegations of unfair search practices that could reshape competition rules across the region’s digital economy.
Investigation Under Digital Markets Act Gains Momentum
The case is being examined by the European Commission under the European Union’s landmark Digital Markets Act (DMA), introduced to curb the dominance of major technology platforms and ensure fair competition.
Launched in March 2024, the investigation focuses on whether Google has been prioritising its own services in search results, potentially disadvantaging rival businesses that rely on online visibility to reach customers.
Industry Groups Demand Swift Action
Several prominent European organizations have jointly urged regulators to conclude the probe without further delay. They argue that prolonged investigations allow alleged anti-competitive practices to continue, putting European companies—especially startups—at a disadvantage.
Signatories include the European Publishers Council, the European Magazine Media Association, the European Tech Alliance, and EU Travel Tech.
In a joint statement, these groups warned that delays in enforcement are affecting innovation, profitability, and growth prospects for regional businesses competing in digital markets.
Google Denies Allegations
Google has rejected claims of bias, stating that its search algorithms are designed to deliver the most relevant and useful results to users. The company has also proposed adjustments to address regulatory concerns.
However, critics argue that these changes are insufficient and fail to address the core issue of market dominance.
Potential Billion-Euro Penalties
If found in violation of the DMA, Google could face significant financial penalties. Under EU rules, fines can reach a substantial percentage of a company’s global turnover, potentially amounting to billions of euros.
Regulators may also impose corrective measures requiring changes to business practices, which could have long-term implications for how digital platforms operate in Europe.
Wider Implications for Big Tech
The case highlights ongoing tensions between European regulators and major U.S. technology firms. In recent years, the EU has taken a more aggressive stance in enforcing competition laws, aiming to create a level playing field for local businesses.
A final ruling against Google could set a major precedent, influencing future enforcement actions and shaping the regulatory landscape for global tech companies operating within Europe.
As scrutiny intensifies, the outcome of the investigation is expected to play a critical role in defining the future of digital competition across the European Union.
AI & Technology
Amazon Faces Potential Criminal Trial in Italy Over €1.2 Billion Tax Evasion Allegations
Milan: U.S. tech giant Amazon is facing the prospect of a major legal showdown in Italy, after prosecutors in Milan formally requested a court to move forward with criminal proceedings over alleged tax evasion totaling approximately ₹12,500 crore (€1.2 billion).
The case targets Amazon’s European division along with four senior executives, marking one of the most significant tax-related investigations involving a global e-commerce platform in Europe.
Trial Push Despite Multi-Million Euro Settlement
The move comes even after Amazon reached a financial settlement with Italian tax authorities in December, agreeing to pay around ₹5,500 crore (€527 million), including interest, to resolve part of the dispute.
Typically, such settlements lead to the closure of criminal investigations. However, Milan prosecutors have opted to proceed, signaling a tougher stance on alleged corporate tax violations.
A preliminary hearing is expected in the coming months, where a judge will decide whether to formally indict the company and its executives or dismiss the case.
Allegations of VAT Evasion Through Marketplace Sellers
At the center of the investigation are claims that Amazon’s platform enabled non-European Union sellers to avoid paying value-added tax (VAT) on goods sold to Italian consumers between 2019 and 2021.
Prosecutors allege that the company’s marketplace structure allowed thousands of foreign vendors—many reportedly based in China—to operate without fully disclosing their identities or tax obligations. This, authorities argue, led to substantial VAT losses for the Italian government.
Under Italian law, online platforms facilitating sales can be held partially liable if third-party sellers fail to comply with tax requirements, a key point in the prosecution’s case.
Italian Government Named as Affected Party
In their filing, prosecutors identified Italy’s Economy Ministry as the injured party, citing significant financial damage resulting from the alleged tax evasion.
Legal experts say the outcome of the case could have wide-ranging implications across the European Union, where VAT systems are harmonized and similar compliance rules apply to digital marketplaces.
Multiple Investigations Add to Pressure
The VAT probe is just one of several legal challenges facing Amazon in Italy. The European Public Prosecutor’s Office is reportedly examining additional tax-related issues covering more recent years.
Meanwhile, Milan authorities are pursuing separate investigations into alleged customs fraud linked to imports from China and whether Amazon maintained an undeclared “permanent establishment” in Italy—potentially exposing it to higher tax liabilities.
In a separate regulatory action, Italy’s data protection authority recently ordered an Amazon unit to stop using personal data from over 1,800 employees at a warehouse near Rome.
Amazon Denies Allegations
Amazon has consistently denied wrongdoing and indicated it will strongly contest the allegations in court if the case proceeds. The company has also warned that prolonged legal uncertainty could impact investor confidence and Italy’s appeal as a destination for international business.
Broader Impact on Europe’s Digital Economy
If the case moves to trial, it could become a landmark moment for the regulation of global e-commerce platforms in Europe. Governments across the region are increasingly scrutinizing how digital marketplaces handle tax compliance, especially in cross-border transactions.
With online retail continuing to expand, regulators are under mounting pressure to ensure that multinational platforms and third-party sellers adhere to the same tax rules as traditional businesses.
-
Business3 years agoPot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business3 years agoNew Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business3 years agoAlabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business3 years agoWashington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business3 years agoMarijuana companies suing US attorney general in federal prohibition challenge
-
Business3 years agoLegal Marijuana Handed A Nothing Burger From NY State
-
Business3 years agoCan Cannabis Help Seasonal Depression
-
Blogs3 years agoCannabis Art Is Flourishing On Etsy
